newsfilter
← Latest News
GlobeNewswire·

Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023

SAN CARLOS, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ:BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform